The Food and Drug Administration today released a to help commercial developers submit emergency use authorization requests for COVID-19 diagnostic tests that can be performed in non-laboratory settings and available by prescription or over-the-counter.

鈥淲e hope that with the innovation we鈥檝e seen in test development, we could see tests that you could buy at a drug store, swab your nose or collect saliva, run the test, and receive results within minutes at home, once these tests become available,鈥 said FDA Commissioner Stephen Hahn, M.D. 鈥淭hese types of tests will be a game changer in our fight against COVID-19 and will be crucial as the nation looks toward reopening.鈥

In other news, FDA yesterday issued emergency use authorizations to  and for molecular diagnostic tests for SARS-CoV-2. The agency also health care providers and the public not to use hand sanitizers containing methanol. FDA has updated its of hand sanitizer products; in most cases, methanol does not appear on the product label.

Related News Articles

Headline
A study published April 8 by the Public Library of Science鈥檚 Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of鈥
Headline
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.鈥檚 nomination for secretary of the Department of Health and Human Services. A鈥
Headline
Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease Control and Prevention. Seasonal flu鈥
Headline
The Occupational Safety and Health Administration Jan. 13 announced that it terminated efforts to establish a final COVID-19 safety standard to protect workers鈥
Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability鈥
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the鈥